SciELO - Scientific Electronic Library Online

vol.155 issue4Escherichia coli enterotoxigénica y enteroagregativa: prevalencia, patogénesis y modelos múridosPapel de las alteraciones del sueño durante la gestación en la programación del feto para el desarrollo de obesidad y enfermedades crónicas degenerativas author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Gaceta médica de México

On-line version ISSN 2696-1288Print version ISSN 0016-3813


LUNA-PALENCIA, Gabriela Rebeca; CORREA-BASURTO, José  and  VASQUEZ-MOCTEZUMA, Ismael. El ácido valproico como agente sensibilizador al tratamiento anticáncer. Gac. Méd. Méx [online]. 2019, vol.155, n.4, pp.417-422.  Epub July 01, 2021. ISSN 2696-1288.

Valproic acid is an antiepileptic drug with more than 50 years of clinical use. In the past decade, its anticancer effects were discovered. Analyses in groups of patients who used this drug for years have shown that it decreases the frequency of head and neck cancer. Recent studies show the anticancer effect of combining valproic acid with chemotherapy, biological therapy and antioxidant systems inhibitors, with exceptional results. In this review, we analyze the metabolism of valproic acid and its application against cancer.

Keywords : Valproic acid; Human cancer therapy; Epigenetic therapy; Histone deacetylase inhibitors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )